AngelLoop

AngelLoop operates as an angel investor network and innovation-focused organization based in Brisbane, Australia, founded in 2017. The organization functions as a connector, linking entrepreneurs with Australia's largest Angel Investor syndicate, which comprises over 400 potential investors. AngelLoop's primary mission is to foster a culture of innovation and entrepreneurship in Australia by helping new ideas reach commercial success. It identifies innovations with high market potential and equips entrepreneurs with the business acumen needed for commercialization.

The company is managed by Simon Horne, an angel investor with 15 years of international entrepreneurial experience, including being the first employee at the Silicon Valley startup BlueJeans. The board of directors includes experienced professionals like Dr. Carrie Hillyard, Dr. Grace Ng, and Dr. Dean Alle, who bring extensive backgrounds in life sciences, venture capital, business scaling, and technology commercialization. AngelLoop was established as a not-for-profit to support the public benefit of bringing more ideas to commercial fruition, though it has faced challenges with its charitable status classification. It operates as a business introductory service, screening and selecting entrepreneurs for opportunities to pitch to the angel network.

AngelLoop provides several programs and services for entrepreneurs. This includes facilitating pitch events and running the "Wings Accelerator," a market-readiness program for entrepreneurs who have developed a minimum viable product (MVP). Additionally, through a partnership with Scaling.Club, it offers a program to help post-seed startups navigate the 'Valley of Death' with mentorship and fractional C-suite support. The organization targets entrepreneurs whose business ideas demonstrate strong customer interest, a sustainable competitive advantage, high growth potential, and the possibility of a 10x return within five years. AngelLoop has actively invested in various sectors, including Business/Productivity Software, Biotechnology, and Surgical Devices, with portfolio companies like Embeint, Gelomics, and Convergence Medical. One of their most recent investments was in Embeint in May 2025.

Keywords: angel investor network, early-stage investment, entrepreneurship support, startup funding, venture capital, commercialization, innovation hub, Australian startups, pitch events, accelerator program, business mentorship, seed funding, high-growth ventures, tech investment, life sciences investment, biotechnology funding, startup ecosystem, investor syndicate, capital raising, new venture support